- Home
- YMM vs HALO Comparison
YMM vs HALO Comparison
Compare YMM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YMM | HALO |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.1B |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | YMM | HALO |
|---|---|---|
| Price | $9.33 | $77.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $12.00 | ★ $78.64 |
| AVG Volume (30 Days) | ★ 5.9M | 1.8M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | N/A | $28.24 |
| Revenue Next Year | $13.05 | $12.56 |
| P/E Ratio | ★ $18.30 | $63.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.46 | $56.05 |
| 52 Week High | $14.07 | $82.26 |
Technical Indicators
Market Signals| Indicator | YMM | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 64.90 | 58.24 |
| Support Level | $8.29 | $67.12 |
| Resistance Level | $9.53 | $82.24 |
| Average True Range (ATR) | 0.28 | 2.41 |
| MACD | 0.13 | -0.31 |
| Stochastic Oscillator | 91.32 | 44.44 |
Price Performance
Historical ComparisonAbout YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.